🇺🇸 FDA
Patent

US 9387214

Method of identifying therapies for pulmonary hypertension

granted A61KA61K31/519A61K31/5575

Quick answer

US patent 9387214 (Method of identifying therapies for pulmonary hypertension) held by United Therapeutics Corporation expires Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United Therapeutics Corporation
Grant date
Tue Jul 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/519, A61K31/5575, A61P, A61P11/00